title: Current options for the treatment of facial angiofibromas.
abstract: Facial angiofibromas are hamartomatous growths that are closely associated with tuberous sclerosis complex and, in fact, they constitute one of the main diagnostic criteria for that disease. These lesions composed of blood vessels and fibrous tissue appear on the face at an early age. Since they have important physical and psychological repercussions for patients, several treatment options have been used to remove them or improve their appearance. However, the lack of treatment guidelines prevents us from developing a common protocol for patients with this condition. The present article aims to review the treatments for facial angiofibromas used to date and to propose a new evidence-based treatment protocol.
authors.affiliation: Servicio de Dermatología, Hospital Universitario Reina Sofía, Córdoba, España. Electronic address: rsalidovallejo@aedv.es.
authors.forename: R
authors.initials: R
authors.lastname: Salido-Vallejo
authors.affiliation: Servicio de Dermatología, Hospital Universitario Reina Sofía, Córdoba, España.
authors.forename: G
authors.initials: G
authors.lastname: Garnacho-Saucedo
authors.affiliation: Servicio de Dermatología, Hospital Universitario Reina Sofía, Córdoba, España.
authors.forename: J C
authors.initials: JC
authors.lastname: Moreno-Giménez
mesh_terms: D000465:Algorithms; D018322:Angiofibroma / Q000628:therapy*; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D005153:Facial Neoplasms / Q000628:therapy*; D006801:Humans; D020123:Sirolimus / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000628:therapy*
chemical_list: D000903:Antibiotics, Antineoplastic; D020123:Sirolimus
keywords: Angiofibroma; Esclerosis tuberosa; Laser therapy; Sirolimus; Terapia láser; Terapéutica; Therapeutics; Tuberous sclerosis